An engineered three-dimensional gastric tumor culture model for evaluating the antitumor activity of immune cells in vitro

Oncology Letters

Volumn 5, Issue 2, 2013, Pages 489-494

  Sun, Peiming ^a   Xu, Yingxin ^a   Du, Xiaohui ^a   Ning, Ning ^a   Sun, Huiwei ^a   Liang, Wentao ^a   Li, Rong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Antitumor activity; Gastric cancer; Immune cells; Three dimensional culture; Tumor model

Indexed keywords

B7 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; LACTATE DEHYDROGENASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL INTERACTION; CELL MIGRATION; CELL STRUCTURE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOKINE INDUCED KILLER CELL; CYTOTOXICITY; DENDRITIC CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYDROGEL; PHASE CONTRAST MICROSCOPY; STOMACH TUMOR; TUMOR MODEL;

EID: 84871536685     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.1021     Document Type: Article

References (30)

1. Santini MT and Rainaldi G: Three-dimensional spheroid model in tumor biology. Pathobiology 67: 148-157, 1999.
2. Smalley KS, Lioni M and Herlyn M: Life isn't flat: taking cancer biology to the next dimension. In Vitro Cell Dev Biol Anim 42: 242-247, 2006.
3. Zaman MH, Trapani LM, Sieminski AL, Mackellar D, GongH, Kamm RD, Wells A, Lauffenburger DA and Matsudaira P: Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc Natl Acad Sci USA 103: 10889-10894, 2006.
4. Wyckoff JB, Wang Y, Lin EY, Li JF, Goswami S, Stanley ER, Segall JE, Pollard JW and Condeelis J: Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 67: 2649-2656, 2007.
5. Vamvakidou AP, Mondrinos MJ, Petushi SP, Garcia FU, LelkesPI and Tozeren A: Heterogeneous breast tumoroids: An in vitro assay for investigating cellular heterogeneity and drug delivery. J Biomol Screen 12: 13-20, 2007.
6. Tang J, Cui J, Chen R, Guo K, Kang X, Li Y, Gao D, Sun L, XuC, Chen J, Tang Z and Liu Y: A three-dimensional cell biology model of human hepatocellular carcinoma in vitro. Tumour Biol 32: 469-479, 2011.
7. Rodday B, Hirschhaeuser F, Walenta S and Mueller-Klieser W: Semiautomatic growth analysis of multicellular tumor spheroids. J Biomol Screen 16: 1119-1124, 2011.
8. Santini MT, Rainaldi G and Indovina PL: Multicellular tumour spheroids in radiation biology. Int J Radiat Biol 75: 787-799, 1999.
9. Oktem G, Bilir A, Selvi N, Yurtseven ME, Vatansever S, Ates U, Uysal A and Omay SB: Chemotherapy influences inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) activity on 3D breast cancer cell line. Oncol Res 16: 195-203, 2006.
10. Ho WJ, Pham EA, Kim JW, Ng CW, Kim JH, Kamei DT and WuBM: Incorporation of multicellular spheroids into 3-D polymeric scaffolds provides an improved tumor model for screening anticancer drugs. Cancer Sci 101: 2637-2643, 2010.
11. Higashiyama M, Okami J, Maeda J, Tokunaga T, FujiwaraA, Kodama K, Imamura F and Kobayashi H: Differences in chemosensitivity between primary and paired metastatic lung cancer tissues: In vitro analysis based on the collagen gel droplet embedded culture drug test (CD-DST). J Thorac Dis 4: 40-47, 2012.
12. Horning JL, Sahoo SK, Vijayaraghavalu S, Dimitrijevic S, VasirJK, Jain TK, Panda AK and Labhasetwar V: 3-D tumor model for in vitro evaluation of anticancer drugs. Mol Pharm 5: 849-862, 2008.
13. Zhao Y, Xu Y, Zhang B, Wu X, Xu F, Liang W, Du X and LiR: In vivo generation of thick, vascularized hepatic tissue from collagen hydrogel-based hepatic units. Tissue Eng Part C Methods 16: 653-659, 2010.
14. Guo XM, Zhao YS, Chang HX, Wang CY, E LL, Zhang XA, Duan CM, Dong LZ, Jiang H, Li J, Song Y and Yang XJ: Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells. Circulation 113: 2229-2237, 2006.
15. Yamada KM and Cukierman E: Modeling tissue morphogenesis and cancer in 3D. Cell 130: 601-610, 2007.
16. Gottfried E, Kunz-Schughart LA, Andreesen R and KreutzM: Brave little world: spheroids as an in vitro model to study tumor-immune-cell interactions. Cell Cycle 5: 691-695, 2006.
17. Kim JW, Ho WJ and Wu BM: The role of the 3D environment in hypoxia-induced drug and apoptosis resistance. Anticancer Res 31: 3237-3245, 2011.
18. Sakai S, Inamoto K, Liu Y, Tanaka S, Arii S and Taya M: Multicellular tumor spheroid formation in duplex microcapsules for analysis of chemosensitivity. Cancer Sci 103: 549-554, 2012.
19. Loessner D, Stok KS, Lutolf MP, Hutmacher DW, Clements JA and Rizzi SC: Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials 31: 8494-8506, 2010.
20. Egeblad M, Rasch MG and Weaver VM: Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol 22: 697-706, 2010.
21. Xu F and Burg KJ: Three-dimensional polymeric systems for cancer cell studies. Cytotechnology 54: 135-143, 2007.
22. Olioso P, Giancola R, Di Riti M, Contento A, Accorsi P and Iacone A: Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial. Hematol Oncol 27: 130-139, 2009.
23. June CH: Adoptive T cell therapy for cancer in the clinic. J Clin Invest 117: 1466-1476, 2007.
24. Zhong R, Teng J, Han B and Zhong H: Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer. Cancer Immunol Immunother 60: 1497-1502, 2011.
25. Zhou P, Liang P, Dong B, Yu X, Han Z and Xu Y: Phase clinical study of combination therapy with microwave ablation and cellular immunotherapy in hepatocellular carcinoma. Cancer Biol Ther 11: 450-456, 2011.
26. Kim HM, Lim J, Park SK, Kang JS, Lee K, Lee CW, Lee KH, YunMJ, Yang KH, Han G, Kwon SW, Kim Y and Han SB: Antitumor activity of cytokine-induced killer cells against human lung cancer. Int Immunopharmacol 7: 1802-1807, 2007.
27. Hu Y, He Y, Srivenugopal KS, Fan S and Jiang Y: In vitro antitumor cytotoxic T lymphocyte response induced by dendritic cells transduced with ΔNp73α recombinant adenovirus. Oncol Rep 18: 1085-1091, 2007.
28. Korpos E, Wu C, Song J, Hallmann R and Sorokin L: Role of the extracellular matrix in lymphocyte migration. Cell Tissue Res 339: 47-57, 2010.
29. Sant S, Hancock MJ, Donnelly JP, Iyer D and KhademhosseiniA: Biomimetic gradient hydrogels for tissue engineering. Can J Chem Eng 88: 899-911, 2010.
30. Lutterbuese R, Raum T, Kischel R, Lutterbuese P, Schlereth B, Schaller E, Mangold S, Rau D, Meier P, Kiener PA, MulgrewK, Oberst MD, Hammond SA, Baeuerle PA and Kufer P: Potent control of tumor growth by CEA/CD3-bispecific single-chain antibody constructs that are not competitively inhibited by soluble CEA. J Immunother 32: 341-352, 2009.